VarCov Co’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$414K Buy
6,285
+1,265
+25% +$98.5K 0.2% 183
2026
Q2
$374K Buy
+5,020
New +$352K 0.14% 238
2026
Q1
– Sell
-4,447
Closed -$340K – 390
2025
Q4
$340K Buy
+4,447
New +$292K 0.13% 258

Other funds holding BBIO

VarCov Co's BBIO Position: Q3 2026 in Review

VarCov Co increased its BridgeBio Pharma (BBIO) stake by 25% in Q3 2026, buying an estimated $98.5K and bringing the position to 6,285 shares worth $414K. The position accounts for 0.2% of the portfolio, ranked #183.

VarCov Co first reported a position in BBIO in Q4 2025 and has held it in 3 quarters since. 471 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • VarCov Co held 6,285 shares of BridgeBio Pharma worth $414K as of Q3 2026.
  • VarCov Co bought 1,265 BridgeBio Pharma shares in Q3 2026, an estimated $98.5K.
  • BridgeBio Pharma made up 0.2% of VarCov Co's portfolio in Q3 2026, its #183 holding.
  • VarCov Co first reported a position in BridgeBio Pharma in Q4 2025 and has held it in 3 quarters since.
  • 471 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.